135 related articles for article (PubMed ID: 34028266)
1. Calcium Carbonate Core-Shell Particles for Incorporation of
Muslimov AR; Antuganov DO; Tarakanchikova YV; Zhukov MV; Nadporojskii MA; Zyuzin MV; Timin AS
ACS Appl Mater Interfaces; 2021 Jun; 13(22):25599-25610. PubMed ID: 34028266
[TBL] [Abstract][Full Text] [Related]
2. An investigation of calcium carbonate core-shell particles for incorporation of
Muslimov AR; Antuganov D; Tarakanchikova YV; Karpov TE; Zhukov MV; Zyuzin MV; Timin AS
J Control Release; 2021 Feb; 330():726-737. PubMed ID: 33428985
[TBL] [Abstract][Full Text] [Related]
3. Radiolabeling Strategies of Micron- and Submicron-Sized Core-Shell Carriers for
Zyuzin MV; Antuganov D; Tarakanchikova YV; Karpov TE; Mashel TV; Gerasimova EN; Peltek OO; Alexandre N; Bruyere S; Kondratenko YA; Muslimov AR; Timin AS
ACS Appl Mater Interfaces; 2020 Jul; 12(28):31137-31147. PubMed ID: 32551479
[TBL] [Abstract][Full Text] [Related]
4. LaPO4 nanoparticles doped with actinium-225 that partially sequester daughter radionuclides.
Woodward J; Kennel SJ; Stuckey A; Osborne D; Wall J; Rondinone AJ; Standaert RF; Mirzadeh S
Bioconjug Chem; 2011 Apr; 22(4):766-76. PubMed ID: 21434681
[TBL] [Abstract][Full Text] [Related]
5. A Genomic Profile of Local Immunity in the Melanoma Microenvironment Following Treatment with α Particle-Emitting Ultrasmall Silica Nanoparticles.
Urbanska AM; Khanin R; Alidori S; Wong S; Mello BP; Almeida BA; Chen F; Ma K; Turker MZ; Korontsvit T; Scheinberg DA; Zanzonico PB; Wiesner U; Bradbury MS; Quinn TP; McDevitt MR
Cancer Biother Radiopharm; 2020 Aug; 35(6):459-473. PubMed ID: 32013538
[TBL] [Abstract][Full Text] [Related]
6. Radioiodination of rhenium cyclized alpha-melanocyte-stimulating hormone resulting in enhanced radioactivity localization and retention in melanoma.
Cheng Z; Chen J; Quinn TP; Jurisson SS
Cancer Res; 2004 Feb; 64(4):1411-8. PubMed ID: 14973076
[TBL] [Abstract][Full Text] [Related]
7. Melanoma Imaging Using
Zhang C; Zhang Z; Lin KS; Lau J; Zeisler J; Colpo N; Perrin DM; Bénard F
Mol Pharm; 2018 Jun; 15(6):2116-2122. PubMed ID: 29714486
[TBL] [Abstract][Full Text] [Related]
8. Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog.
Cheng Z; Zhang L; Graves E; Xiong Z; Dandekar M; Chen X; Gambhir SS
J Nucl Med; 2007 Jun; 48(6):987-94. PubMed ID: 17504880
[TBL] [Abstract][Full Text] [Related]
9.
Bridgwater C; Geller A; Hu X; Burlison JA; Zhang HG; Yan J; Guo H
Cancer Biother Radiopharm; 2020 Oct; 35(8):549-557. PubMed ID: 32315549
[TBL] [Abstract][Full Text] [Related]
10. Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes.
Ruggiero A; Villa CH; Holland JP; Sprinkle SR; May C; Lewis JS; Scheinberg DA; McDevitt MR
Int J Nanomedicine; 2010 Oct; 5():783-802. PubMed ID: 21042424
[TBL] [Abstract][Full Text] [Related]
11. A Metabolically Stable Boron-Derived Tyrosine Serves as a Theranostic Agent for Positron Emission Tomography Guided Boron Neutron Capture Therapy.
Li J; Shi Y; Zhang Z; Liu H; Lang L; Liu T; Chen X; Liu Z
Bioconjug Chem; 2019 Nov; 30(11):2870-2878. PubMed ID: 31593447
[TBL] [Abstract][Full Text] [Related]
12. A review of recent advancements in Actinium-225 labeled compounds and biomolecules for therapeutic purposes.
Hassan M; Bokhari TH; Lodhi NA; Khosa MK; Usman M
Chem Biol Drug Des; 2023 Nov; 102(5):1276-1292. PubMed ID: 37715360
[TBL] [Abstract][Full Text] [Related]
13. Biocompatible conjugated polymer nanoparticles labeled with
Chen X; Liang R; Liu W; Ma H; Bai C; Xiong Y; Lan T; Liao J; Yang Y; Yang J; Li F; Liu N
Bioorg Med Chem; 2023 Dec; 96():117517. PubMed ID: 37939492
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of [
Cortez A; Josefsson A; McCarty G; Shtekler AE; Rao A; Austin Z; Nedrow JR
Nucl Med Biol; 2020; 88-89():62-72. PubMed ID: 32799049
[TBL] [Abstract][Full Text] [Related]
15. Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma:
Watabe T; Liu Y; Kaneda-Nakashima K; Shirakami Y; Lindner T; Ooe K; Toyoshima A; Nagata K; Shimosegawa E; Haberkorn U; Kratochwil C; Shinohara A; Giesel F; Hatazawa J
J Nucl Med; 2020 Apr; 61(4):563-569. PubMed ID: 31586001
[TBL] [Abstract][Full Text] [Related]
16. What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between
Bailly C; Gouard S; Guérard F; Chalopin B; Carlier T; Faivre-Chauvet A; Remaud-Le Saëc P; Bourgeois M; Chouin N; Rbah-Vidal L; Tripier R; Haddad F; Kraeber-Bodéré F; Bodet-Milin C; Chérel M
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137758
[TBL] [Abstract][Full Text] [Related]
17. Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody.
Rylova SN; Del Pozzo L; Klingeberg C; Tönnesmann R; Illert AL; Meyer PT; Maecke HR; Holland JP
J Nucl Med; 2016 Jan; 57(1):96-102. PubMed ID: 26514172
[TBL] [Abstract][Full Text] [Related]
18. Molecular Imaging of Inflammation in a Mouse Model of Atherosclerosis Using a Zirconium-89-Labeled Probe.
Ahmed M; Tegnebratt T; Tran TA; Lu L; Damberg P; Gisterå A; Tarnawski L; Bone D; Hedin U; Eriksson P; Holmin S; Gustafsson B; Caidahl K
Int J Nanomedicine; 2020; 15():6137-6152. PubMed ID: 32884268
[TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of (89)Zr-Zevalin for monitoring of (90)Y-Zevalin biodistribution with positron emission tomography.
Perk LR; Visser OJ; Stigter-van Walsum M; Vosjan MJ; Visser GW; Zijlstra JM; Huijgens PC; van Dongen GA
Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1337-45. PubMed ID: 16832633
[TBL] [Abstract][Full Text] [Related]
20. Efficient Distribution of a Novel Zirconium-89 Labeled Anti-cd20 Antibody Following Subcutaneous and Intravenous Administration in Control and Experimental Autoimmune Encephalomyelitis-Variant Mice.
Migotto MA; Mardon K; Orian J; Weckbecker G; Kneuer R; Bhalla R; Reutens DC
Front Immunol; 2019; 10():2437. PubMed ID: 31681317
[No Abstract] [Full Text] [Related]
[Next] [New Search]
